Icon

JAYPIRCA - (50MG, 100MG)

PIRTOBRUTINIB None
50MG, 100MG
Less Than $1000 mn
None None
None None
None None
JAYPIRCA is a kinase inhibitor indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic therapy, including a BTK inh bitor.
Yes
JAYPIRCA Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.